Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q21006

Entry ID Method Resolution Chain Position Source
AF-Q21006-F1 Predicted AlphaFoldDB

No variants for Q21006

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q21006

No associated diseases with Q21006

2 regional properties for Q21006

Type Name Position InterPro Accession
domain Nuclear hormone receptor, ligand-binding domain 306 - 581 IPR000536
domain Zinc finger, nuclear hormone receptor-type 148 - 223 IPR001628

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

3 GO annotations of molecular function

Name Definition
nuclear receptor activity A DNA-binding transcription factor activity regulated by binding to a ligand that modulates the transcription of specific gene sets transcribed by RNA polymerase II. Nuclear receptor ligands are usually lipid-based (such as a steroid hormone) and the binding of the ligand to its receptor often occurs in the cytoplasm, which leads to its tranlocation to the nucleus.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
zinc ion binding Binding to a zinc ion (Zn).

3 GO annotations of biological process

Name Definition
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

31 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9TTR7 NR2F2 COUP transcription factor 2 Bos taurus (Bovine) PR
O18971 PPARG Peroxisome proliferator-activated receptor gamma Bos taurus (Bovine) PR
Q90733 NR2F2 COUP transcription factor 2 Gallus gallus (Chicken) PR
P68306 THRB Thyroid hormone receptor beta Gallus gallus (Chicken) PR
A7X8B3 PGR Progesterone receptor Pan troglodytes (Chimpanzee) SS
P37231 PPARG Peroxisome proliferator-activated receptor gamma Homo sapiens (Human) PR
P10588 NR2F6 Nuclear receptor subfamily 2 group F member 6 Homo sapiens (Human) PR
P06401 PGR Progesterone receptor Homo sapiens (Human) EV
P10589 NR2F1 COUP transcription factor 1 Homo sapiens (Human) PR
O75469 NR1I2 Nuclear receptor subfamily 1 group I member 2 Homo sapiens (Human) PR
P24468 NR2F2 COUP transcription factor 2 Homo sapiens (Human) PR
P49116 NR2C2 Nuclear receptor subfamily 2 group C member 2 Homo sapiens (Human) PR
P41235 HNF4A Hepatocyte nuclear factor 4-alpha Homo sapiens (Human) PR
P35396 Ppard Peroxisome proliferator-activated receptor delta Mus musculus (Mouse) PR
P43136 Nr2f6 Nuclear receptor subfamily 2 group F member 6 Mus musculus (Mouse) PR
P43135 Nr2f2 COUP transcription factor 2 Mus musculus (Mouse) PR
Q00175 Pgr Progesterone receptor Mus musculus (Mouse) SS
Q9Z0Y9 Nr1h3 Oxysterols receptor LXR-alpha Mus musculus (Mouse) PR
P49698 Hnf4a Hepatocyte nuclear factor 4-alpha Mus musculus (Mouse) PR
O62807 PPARG Peroxisome proliferator-activated receptor gamma Sus scrofa (Pig) PR
O09018 Nr2f2 COUP transcription factor 2 Rattus norvegicus (Rat) PR
Q63449 Pgr Progesterone receptor Rattus norvegicus (Rat) SS
P22449 Hnf4a Hepatocyte nuclear factor 4-alpha Rattus norvegicus (Rat) PR
Q8SQ01 NR1I2 Nuclear receptor subfamily 1 group I member 2 Macaca mulatta (Rhesus macaque) PR
G5EFF5 daf-12 Nuclear hormone receptor family member daf-12 Caenorhabditis elegans PR
O45460 nhr-54 Nuclear hormone receptor family member nhr-54 Caenorhabditis elegans PR
Q20765 nhr-7 Nuclear hormone receptor family member nhr-7 Caenorhabditis elegans PR
O17928 nhr-52 Nuclear hormone receptor family member nhr-52 Caenorhabditis elegans PR
Q21878 nhr-1 Nuclear hormone receptor family member nhr-1 Caenorhabditis elegans PR
O18141 nhr-79 Nuclear hormone receptor family member nhr-79 Caenorhabditis elegans PR
Q6PH18 nr2f1b Nuclear receptor subfamily 2 group F member 1-B Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MTDYCIFNIS WMSDRFGCET GNEDVQECID KSPNGSPTTS TTHRRQNSSS GLEPARKRPK
70 80 90 100 110 120
LSPPVLTAMP LDLTDAVSPN ESQACTSSLK GVVTAAGAAQ MSVADRMTSS SVAPPLCIVP
130 140 150 160 170 180
RSVEFINPKT EDMSMDIPMG NVQSEFTGLK CRVCGDSRAG RHYGTIACNG CKGFFRRSIW
190 200 210 220 230 240
EQRDYVCRFG GKCLVVQEYR NRCRACRLRK CFTVGMDARA VQSERDKHKK NPKDSNNEGS
250 260 270 280 290 300
TSPQYPTAST PISIPSTSTS QTPTSSVNSY NFQNIPGIVS RSFSENLIMR DNSVPVMETS
310 320 330 340 350 360
QSAALSHVPL VRYLIDLEKA TDNLIDENCD FMSMEFDQLC RVDVTIEAAF RQPGVVAKRT
370 380 390 400 410 420
PPRWLALERL TTLEDVHIAW CRSFVLCIDY AKIMKDYQEL SPTDQFTLLR NRVISVNWLC
430 440 450 460 470 480
HTYKTFKAGC DGVALVNGSW YPRDKELQKQ LDPGCNHYFR ILSEHLMEDL VIPMREMDMD
490 500 510 520 530 540
EGEFVILKAL ILFRAHRRLS EEGRAHIKRV RDKYIEALYQ HVQHQHRHFS SVQTSMRISK
550 560 570 580 590 600
ILLLLPSIEH LSQQEDDNVQ FLALFNLANL NGLPYELHSS IKQHIPNGDD SDDTQVNEVT
610 620 630
SNNDGPRSSE SSHTPQSVST SQFLEFKPSL H